Skip to main content
EXACT Therapeutics AS logo

EXACT Therapeutics AS — Investor Relations & Filings

Ticker · EXTX ISIN · NO0010852213 LEI · 2138006ZE5JAL39AGD55 OL Manufacturing
Open in API
Filings indexed 233 across all filing types
Latest filing 2021-06-01 AGM Information
Country NO Norway
Listing OL EXTX

About EXACT Therapeutics AS

https://www.exact-tx.com/

EXACT Therapeutics AS is a clinical-stage biopharmaceutical company developing its proprietary technology platform, Acoustic Cluster Therapy (ACT®), for targeted therapeutic enhancement. The ACT® platform uses ultrasound to amplify the effect of co-administered drugs, with a primary focus on oncology. Its biomechanical mode of action increases the local uptake of therapeutics from blood vessels into the surrounding tissue, including across the blood-brain barrier, without requiring drug reformulation. This non-invasive technology is designed to be compatible with standard ultrasound systems. The company's pipeline includes the ENACT study, a Phase 2 trial evaluating ACT® in patients with locally advanced pancreatic cancer, following the completion of the ACTIVATE Phase 1 study in patients with liver metastases.

Recent filings

Filing Released Lang Actions
EXACT Therapeutics AS: Minutes of Annual General Meeting 2021
AGM Information Classification · 100% confidence The document text explicitly states in both Norwegian and English: "MINUTES OF ANNUAL GENERAL MEETING" and "PROTOKOLL FRA ORDINÆR GENERALFORSAMLING". The content details the proceedings, resolutions passed (approval of financial statements, election of board members, approval of remuneration), and voting results, which are the defining characteristics of meeting minutes, specifically for an Annual General Meeting (AGM). This directly maps to the AGM-R filing type.
2021-06-01 English
EXACT Therapeutics AS: Minutes of Annual General Meeting 2021
AGM Information Classification · 99% confidence The document explicitly states it contains the 'Minutes of Annual General Meeting 2021' for EXACT Therapeutics AS. This directly corresponds to the definition of AGM Information (Code: AGM-R), which covers presentations and materials shared during the Annual General Meeting (AGM). Although it mentions 'enclosed the minutes', the primary content *is* the minutes/record of the AGM proceedings, making AGM-R the most specific fit over a general RPA or RNS.
2021-06-01 English
EXACT THERAPEUTICS ANNOUNCES CLINICAL TRIAL UPDATE
Regulatory Filings Classification · 90% confidence The document is titled "EXACT THERAPEUTICS ANNOUNCES CLINICAL TRIAL UPDATE" and provides specific details about the status of the Phase I ACTIVATE study, including enrollment challenges due to COVID-19, data evaluability, planned protocol amendments, and the expected restart of enrollment. It also mentions internal governance improvements. This content is a specific operational update related to ongoing clinical development and internal processes, rather than a full financial report (10-K, IR), an earnings release (ER), or a formal management discussion (MDA). Since there is no specific category for a 'Clinical Trial Update,' and it is a substantive announcement about company operations and progress, it best fits the general 'Regulatory Filings' (RNS) category as a miscellaneous, non-standard announcement, or potentially 'LTR' if the trial issues were regulatory in nature, but 'RNS' is the most appropriate fallback for operational news that isn't a core financial filing or management change.
2021-05-28 English
EXACT Therapeutics AS - Notice of Annual General Meeting 2021
AGM Information Classification · 100% confidence The document is explicitly titled "INNKALLING TIL ORDINÆR GENERALFORSAMLING" (NOTICE OF ANNUAL GENERAL MEETING) in Norwegian and "NOTICE OF ANNUAL GENERAL MEETING" in English. It details the agenda for the meeting, including items like the approval of the annual report, election of board members, and remuneration proposals, which are standard components of an AGM notice. Although it mentions the Annual Report (årsrapport) is available elsewhere, the document itself is the formal notice convening the meeting. This directly corresponds to the definition of AGM Information (AGM-R).
2021-05-25 English
EXACT Therapeutics AS - Notice of Annual General Meeting 2021
AGM Information Classification · 98% confidence The document explicitly states it is a 'Notice of Annual General Meeting 2021' for EXACT Therapeutics AS. This directly corresponds to the definition of AGM Information (Code: AGM-R), which covers presentations and materials shared during the Annual General Meeting. Although it is a notice, the content is central to the AGM proceedings, making AGM-R the most specific fit over a general RPA or RNS.
2021-05-25 English
EXACT THERAPEUTICS ANNOUNCES GRANTING OF PATENT IN JAPAN FOR ACOUSTIC CLUSTER THERAPY
Regulatory Filings Classification · 100% confidence The document is a press release titled "EXACT THERAPEUTICS ANNOUNCES GRANTING OF PATENT IN JAPAN FOR ACOUSTIC CLUSTER THERAPY". It details the granting of a patent in Japan for the company's core technology (Acoustic Cluster Therapy - ACT®). This type of announcement, concerning intellectual property (IP) and technology protection, does not fit neatly into standard financial reports (10-K, IR, ER) or corporate governance documents (DEF 14A, CGR). It is a specific corporate update related to its assets and strategy. Since there is no specific code for 'Patent Grant Announcement', the most appropriate general category for miscellaneous, non-standard regulatory or corporate news that doesn't fit elsewhere is 'Regulatory Filings' (RNS), as it is an official announcement of a material event.
2021-05-19 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.